Associated Banc Corp Sells 5,948 Shares of iShares Biotechnology ETF $IBB

Associated Banc Corp trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 13.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,134 shares of the financial services provider’s stock after selling 5,948 shares during the period. Associated Banc Corp owned approximately 0.09% of iShares Biotechnology ETF worth $4,698,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in IBB. Brighton Jones LLC bought a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at about $201,000. Avantax Advisory Services Inc. boosted its position in iShares Biotechnology ETF by 5.2% during the first quarter. Avantax Advisory Services Inc. now owns 6,337 shares of the financial services provider’s stock valued at $810,000 after purchasing an additional 314 shares during the last quarter. HB Wealth Management LLC grew its stake in iShares Biotechnology ETF by 56.3% in the first quarter. HB Wealth Management LLC now owns 3,728 shares of the financial services provider’s stock valued at $477,000 after purchasing an additional 1,343 shares in the last quarter. Ramirez Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $26,000. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $45,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $172.33 on Wednesday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $172.41. The stock has a 50 day moving average of $154.57 and a 200-day moving average of $139.36.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.